Vericel (VCEL) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vericel Corporation  (NASDAQ: VCEL)


Vericel's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Vericel's ROA in the third quarter of 2026?
Vericel Corporation achieved a return on average assets (ROA) of 6.71 % in its third quarter of 2026, this is above VCEL's average return on assets of -36.19%.
Vericel Corporation assets over the 12 months ending in its third quarter of 2026 are valued at $496 million

ROA has improved compared to 5.04% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 151 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 1259, from total ROA ranking in the second quarter of 2026 at 1698.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 14.08 % 13.56 % 14.38 % 34.09 % 48.81 %
Y / Y Net Income Change 179.09 % - - 17.35 % -
Net Income (TTM) in million 33 24 21 17 13
Return On Assets (TTM) 6.71 % 5.04 % 4.61 % 3.67 % 3.12 %
VCEL's Total Ranking # 1259 # 1698 # 1606 # 1931 # 2321
Total Assets (TTM) in million 517 495 486 488 453
Seq. Total Assets Change 4.54 % 1.86 % -0.48 % 7.65 % 4.06 %
Seq. Net Income Change 541.93 % - - 358.08 % -

VCEL's 5 Years Annual ROA >> Back to VCEL Management Effectiveness >> Compare VCEL ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 16
Sector # 152
Overall # 1167

Return On Assets Statistics
High Average Low
5.02 %
-36.19 %
-174.75 %
(Jun 30 2026)   (Sep 30 2013)





Financial Statements
Vericel's Assets $ 517 million VCEL's Balance sheet
Vericel's Income $ 14 million Quarterly VCEL's Income Statement
VCEL's Income by Division See VCEL's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 50.96 % 29.14 % 20.25 % 17.66 % 27.94 %
Total Assets in million 549 364 282 234 199
Y / Y Net Income Change 59.41 % - - - -
Net Income in million 17 10 -3 -17 -7
Annual Return On Assets 3.01 % 2.85 % -1.13 % -7.13 % -3.75 %

VCEL's 5 Years Annual ROA >> Back to VCEL Management Effectiveness >> Compare VCEL ROA to its Competitors



Comment on VCEL's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 3.01 % compared to prior year, due to annual net income growth of 59.41 % to $16.52 million, while value of Vericel's overall assets grew just by 50.96 % to $549.36 million, compared to $549.36 a year before.


More Return On Assets Ratios
VCEL's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VCEL's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VCEL's Competitors
Subscribers only: Roa for Vericel's Suppliers
Subscribers only: Return On Assets for VCEL's Customers

You may also want to know
VCEL's Roi VCEL's Inventory Turnover Ratio VCEL's Growth Rates VCEL's Dividend Comparisons
VCEL's Profitability Ratios VCEL's Asset Turnover Ratio VCEL's Dividend Growth
VCEL's Roe VCEL's Valuation Ratios VCEL's Financial Strength Ratios VCEL's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Alector Inc   18.37 %
Corcept Therapeutics Inc  18.09 %
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %
Inspire Medical Systems inc   10.89 %
Transmedics Group Inc   10.67 %
Bristol myers Squibb Company  10.47 %
Lemaitre Vascular Inc   10.28 %
Bio rad Laboratories Inc   9.88 %
3m Company  9.60 %
Bioventus Inc   9.47 %
Medinotec Inc   8.67 %

Date modified: 2026-11-06T12:54:23+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.